Compound Detail
CHEMBL5943007
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1nc(N[C@H](C)c2cccc3c2CCC3(F)F)c2cn(C34CCN(CC3)C4)c(=O)c(C)c2n1
Basic Information
| ChEMBL ID | CHEMBL5943007 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UEDVLDGDODTXMV-MRXNPFEDSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
465.6
MW (Da)
4.42
ALogP
6
HBA
1
HBD
63.0
PSA (Ų)
0.62
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SOS1-KRAS CHEMBL5465393 | IC50 | 8.7 | 8.7 | 2.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SOS1-KRAS | IC50 | = | 2.0 | nM | 8.7 | TBDAlphaScreen Binding Assay: Compounds are diluted to a final start concentrati... | - |
Data from ChEMBL 36 via Core Engine